Kamari Pharma is a clinical stage biotechnology company developing “first and best in class” treatments of rare and severe genetic skin diseases, such as Keratoderma and Ichthyosis.

Content Locked
Login or Register a FREE account to continue browsing our content
2018
Tel Aviv, Israel
Israel

11 - 50
Series A| Funding Round | Announced Date | Disclosed Investors | Round Amount (USD) |
|---|
Content Locked
Login or Register a FREE account to continue browsing our content
Register for our free weekly newsletter
Stay up to date with the latest news, special reports, videos, infobytes, and features on the region's most notable entrepreneurial ecosystems